Shaanxi Meibang Pharmaceutical Group Co., Ltd.SSE: 605033

Indicative Announcement on Change in Shareholding Interests

Jul 19, 2025 · Issued by Shaanxi Meibang Pharmaceutical Group Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Jul 19, 2025

On 6ix: 6ix.com/news/indicative-announcement-on-change-in-shareholding-interests

Indicative Announcement on Change in Shareholding Interests

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Shaanxi Meibang Pharmaceutical Group Co., Ltd. on 6ix

Earlier from Shaanxi Meibang Pharmaceutical

Indicative Announcement on Progress in Shareholding Reduction by Shareholder and Disclosure of 1% Change in Shareholding InterestsJul 9, 2025
Announcement on Redemption of Temporarily Idle Raised Funds Used for Cash Management upon Expiration and Continuously Conducting Cash ManagementJun 18, 2025
Announcement on Share Reduction Plan for ShareholdersJun 4, 2025
Announcement on Resolution of the 2024 Annual General MeetingMay 17, 2025
Announcement on Attending 2025 Collective Reception Day for Investors of Listed Companies in Shaanxi Jurisdiction and 2024 Annual Performance BriefingMay 14, 2025

Later from Shaanxi Meibang Pharmaceutical

Announcement on Result of Shareholding Reduction by Partial ShareholdersJul 24, 2025
Announcement on Canceling the Board of Supervisors and Amending the "Articles of Association" and Some Corporate SystemsAug 27, 2025
Announcement on Convening the 2025 Semi-annual Performance BriefingSep 13, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025Sep 27, 2025
Report for Q3 2025Oct 29, 2025

All Shaanxi Meibang Pharmaceutical news releases

Follow Shaanxi Meibang Pharmaceutical into a list and get an email when it puts out news.

Follow Shaanxi Meibang Pharmaceutical